Business Description
Nektar Therapeutics is a San Francisco-based biopharmaceutical company founded in 1990 that researches and develops treatments for autoimmune, inflammatory, fibrotic, and oncological conditions. Its pipeline includes several compounds at various stages of clinical development, targeting diseases such as ulcerative colitis, multiple sclerosis, and certain cancers. The company works alongside a number of major pharmaceutical partners, including Pfizer, AstraZeneca, Bristol-Myers Squibb, and Merck, among others.
